Concepts (163)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Lung Diseases, Interstitial | 6 | 2024 | 940 | 1.540 |
Why?
|
| Lung Injury | 2 | 2020 | 432 | 1.000 |
Why?
|
| Flavoring Agents | 1 | 2020 | 54 | 0.680 |
Why?
|
| Cannabidiol | 1 | 2020 | 123 | 0.620 |
Why?
|
| Rare Diseases | 1 | 2020 | 630 | 0.470 |
Why?
|
| Fellowships and Scholarships | 1 | 2022 | 1134 | 0.440 |
Why?
|
| Lung | 5 | 2023 | 10068 | 0.350 |
Why?
|
| Lung Diseases | 4 | 2024 | 1940 | 0.330 |
Why?
|
| Bronchiolitis Obliterans | 2 | 2020 | 221 | 0.270 |
Why?
|
| Superior Mesenteric Artery Syndrome | 1 | 2005 | 6 | 0.260 |
Why?
|
| ATP-Binding Cassette Transporters | 2 | 2023 | 566 | 0.260 |
Why?
|
| Pulmonary Medicine | 2 | 2017 | 223 | 0.230 |
Why?
|
| Bread | 1 | 2022 | 23 | 0.210 |
Why?
|
| Diagnostic Techniques, Respiratory System | 1 | 2020 | 13 | 0.170 |
Why?
|
| Foundations | 1 | 2020 | 95 | 0.170 |
Why?
|
| Niemann-Pick Disease, Type C | 1 | 2019 | 57 | 0.160 |
Why?
|
| Hemoptysis | 1 | 2019 | 152 | 0.150 |
Why?
|
| Child | 16 | 2024 | 80670 | 0.150 |
Why?
|
| Membrane Transport Modulators | 1 | 2017 | 24 | 0.140 |
Why?
|
| Aldehyde Oxidoreductases | 1 | 2017 | 88 | 0.140 |
Why?
|
| Vascular Endothelial Growth Factor D | 1 | 2016 | 61 | 0.140 |
Why?
|
| Patient Care Management | 1 | 2020 | 302 | 0.130 |
Why?
|
| Adenosine Triphosphate | 1 | 2023 | 2001 | 0.130 |
Why?
|
| Benzodioxoles | 1 | 2017 | 80 | 0.130 |
Why?
|
| Chylothorax | 1 | 2017 | 83 | 0.130 |
Why?
|
| Noonan Syndrome | 1 | 2017 | 122 | 0.130 |
Why?
|
| Aminophenols | 1 | 2017 | 93 | 0.130 |
Why?
|
| Nicotine | 1 | 2020 | 680 | 0.130 |
Why?
|
| Pulmonary Veno-Occlusive Disease | 1 | 2015 | 64 | 0.120 |
Why?
|
| Transplantation Immunology | 1 | 2017 | 540 | 0.120 |
Why?
|
| Rifampin | 1 | 2017 | 350 | 0.120 |
Why?
|
| Weight Loss | 1 | 2005 | 2712 | 0.110 |
Why?
|
| Tomography, X-Ray Computed | 6 | 2020 | 20710 | 0.110 |
Why?
|
| Cystic Fibrosis Transmembrane Conductance Regulator | 1 | 2017 | 452 | 0.110 |
Why?
|
| Quinolones | 1 | 2017 | 389 | 0.110 |
Why?
|
| Ciliary Motility Disorders | 1 | 2013 | 51 | 0.110 |
Why?
|
| Aminopyridines | 1 | 2017 | 577 | 0.100 |
Why?
|
| Humans | 29 | 2024 | 766812 | 0.100 |
Why?
|
| Motivation | 1 | 2022 | 2020 | 0.100 |
Why?
|
| Respiratory Distress Syndrome, Newborn | 1 | 2014 | 239 | 0.100 |
Why?
|
| Respiratory Tract Infections | 1 | 2020 | 1008 | 0.100 |
Why?
|
| Research | 1 | 2020 | 1977 | 0.100 |
Why?
|
| Pediatrics | 2 | 2017 | 3614 | 0.100 |
Why?
|
| Mutation | 5 | 2023 | 30214 | 0.090 |
Why?
|
| Infant | 13 | 2020 | 36459 | 0.090 |
Why?
|
| NFATC Transcription Factors | 1 | 2013 | 393 | 0.090 |
Why?
|
| Trachea | 1 | 2017 | 1094 | 0.090 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2020 | 1884 | 0.090 |
Why?
|
| Respiration Disorders | 1 | 2014 | 364 | 0.090 |
Why?
|
| Spirometry | 1 | 2014 | 929 | 0.090 |
Why?
|
| Expiratory Reserve Volume | 1 | 2010 | 9 | 0.090 |
Why?
|
| Tracheomalacia | 1 | 2010 | 63 | 0.080 |
Why?
|
| Lung Volume Measurements | 1 | 2010 | 381 | 0.080 |
Why?
|
| Cilia | 1 | 2013 | 498 | 0.080 |
Why?
|
| Radiography, Thoracic | 2 | 2016 | 1320 | 0.080 |
Why?
|
| Vascular Diseases | 1 | 2016 | 1161 | 0.080 |
Why?
|
| Adolescent | 7 | 2022 | 88902 | 0.070 |
Why?
|
| Fontan Procedure | 1 | 2014 | 805 | 0.070 |
Why?
|
| Cystic Fibrosis | 1 | 2017 | 1285 | 0.070 |
Why?
|
| Child, Preschool | 10 | 2020 | 42577 | 0.070 |
Why?
|
| Hemorrhage | 1 | 2018 | 3464 | 0.070 |
Why?
|
| Congenital Abnormalities | 1 | 2011 | 703 | 0.070 |
Why?
|
| Exercise Test | 1 | 2014 | 2188 | 0.060 |
Why?
|
| Biopsy | 2 | 2019 | 6779 | 0.060 |
Why?
|
| Societies, Medical | 1 | 2017 | 3957 | 0.060 |
Why?
|
| Education, Medical, Graduate | 1 | 2017 | 2418 | 0.060 |
Why?
|
| Genetic Association Studies | 1 | 2014 | 2744 | 0.060 |
Why?
|
| Infant, Newborn | 7 | 2019 | 26387 | 0.060 |
Why?
|
| Curriculum | 1 | 2017 | 3783 | 0.050 |
Why?
|
| Male | 17 | 2020 | 364154 | 0.050 |
Why?
|
| Vomiting | 1 | 2005 | 652 | 0.050 |
Why?
|
| Heart Defects, Congenital | 1 | 2018 | 4712 | 0.050 |
Why?
|
| Anti-Bacterial Agents | 1 | 2020 | 7475 | 0.050 |
Why?
|
| Tumor Microenvironment | 1 | 2013 | 3942 | 0.040 |
Why?
|
| Female | 15 | 2020 | 396532 | 0.040 |
Why?
|
| Neuroendocrine Cells | 1 | 2020 | 61 | 0.040 |
Why?
|
| Genetic Markers | 2 | 2017 | 2603 | 0.040 |
Why?
|
| Practice Guidelines as Topic | 1 | 2016 | 7430 | 0.040 |
Why?
|
| HIV Infections | 1 | 2005 | 17532 | 0.040 |
Why?
|
| Young Adult | 3 | 2020 | 59939 | 0.040 |
Why?
|
| Algorithms | 2 | 2016 | 14073 | 0.040 |
Why?
|
| Asthma | 1 | 2017 | 6266 | 0.040 |
Why?
|
| Haploinsufficiency | 1 | 2020 | 334 | 0.040 |
Why?
|
| Bronchiectasis | 1 | 2019 | 141 | 0.040 |
Why?
|
| Exercise | 1 | 2014 | 5945 | 0.040 |
Why?
|
| Retrospective Studies | 7 | 2020 | 81657 | 0.030 |
Why?
|
| Antiretroviral Therapy, Highly Active | 1 | 2005 | 1900 | 0.030 |
Why?
|
| Systemic Inflammatory Response Syndrome | 1 | 2022 | 621 | 0.030 |
Why?
|
| Hyperplasia | 1 | 2020 | 1150 | 0.030 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2013 | 8623 | 0.030 |
Why?
|
| Recurrence | 2 | 2019 | 8507 | 0.030 |
Why?
|
| Biological Availability | 1 | 2017 | 387 | 0.030 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 11 | 1 | 2017 | 224 | 0.030 |
Why?
|
| Adult | 5 | 2020 | 223305 | 0.030 |
Why?
|
| Histone-Lysine N-Methyltransferase | 1 | 2020 | 699 | 0.030 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2016 | 18076 | 0.030 |
Why?
|
| Isoantigens | 1 | 2017 | 562 | 0.030 |
Why?
|
| Chickens | 1 | 2016 | 843 | 0.030 |
Why?
|
| Pulmonary Alveoli | 1 | 2016 | 665 | 0.030 |
Why?
|
| United States | 5 | 2020 | 72945 | 0.030 |
Why?
|
| Pharmacogenetics | 1 | 2017 | 682 | 0.030 |
Why?
|
| Drosophila | 1 | 2020 | 1509 | 0.030 |
Why?
|
| Drug Interactions | 1 | 2017 | 1419 | 0.020 |
Why?
|
| Biphenyl Compounds | 1 | 2017 | 1026 | 0.020 |
Why?
|
| Radiographic Image Enhancement | 1 | 2016 | 873 | 0.020 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2013 | 685 | 0.020 |
Why?
|
| Immunity, Cellular | 1 | 2017 | 1560 | 0.020 |
Why?
|
| Drosophila melanogaster | 1 | 2020 | 1725 | 0.020 |
Why?
|
| Drug Monitoring | 1 | 2017 | 962 | 0.020 |
Why?
|
| Drug Combinations | 1 | 2017 | 2085 | 0.020 |
Why?
|
| Anti-HIV Agents | 1 | 2005 | 4561 | 0.020 |
Why?
|
| Europe | 1 | 2016 | 3430 | 0.020 |
Why?
|
| Homozygote | 1 | 2014 | 1775 | 0.020 |
Why?
|
| Neoplasm Transplantation | 1 | 2013 | 2012 | 0.020 |
Why?
|
| Exercise Tolerance | 1 | 2014 | 845 | 0.020 |
Why?
|
| Specimen Handling | 1 | 2013 | 706 | 0.020 |
Why?
|
| Mice, Inbred BALB C | 1 | 2017 | 6225 | 0.020 |
Why?
|
| Up-Regulation | 1 | 2017 | 4143 | 0.020 |
Why?
|
| Immune Tolerance | 1 | 2017 | 2328 | 0.020 |
Why?
|
| Follow-Up Studies | 2 | 2019 | 39312 | 0.020 |
Why?
|
| Heterozygote | 1 | 2014 | 2795 | 0.020 |
Why?
|
| Tissue Donors | 1 | 2017 | 2392 | 0.020 |
Why?
|
| Odds Ratio | 1 | 2019 | 9661 | 0.020 |
Why?
|
| Mice, Nude | 1 | 2013 | 3618 | 0.020 |
Why?
|
| Boston | 1 | 2019 | 9346 | 0.020 |
Why?
|
| Larynx | 1 | 2011 | 492 | 0.020 |
Why?
|
| Heart Diseases | 1 | 2019 | 2817 | 0.020 |
Why?
|
| Neovascularization, Pathologic | 1 | 2016 | 2631 | 0.020 |
Why?
|
| Graft Survival | 1 | 2017 | 3904 | 0.020 |
Why?
|
| Lymphocyte Activation | 1 | 2017 | 5502 | 0.020 |
Why?
|
| Disease Models, Animal | 2 | 2017 | 18329 | 0.020 |
Why?
|
| Family | 1 | 2016 | 3209 | 0.020 |
Why?
|
| Comorbidity | 1 | 2020 | 10580 | 0.020 |
Why?
|
| Survival Rate | 1 | 2019 | 12826 | 0.020 |
Why?
|
| Epithelial Cells | 1 | 2017 | 3698 | 0.010 |
Why?
|
| Animals | 4 | 2020 | 168939 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2017 | 10745 | 0.010 |
Why?
|
| Lung Transplantation | 1 | 2014 | 1310 | 0.010 |
Why?
|
| Logistic Models | 1 | 2019 | 13276 | 0.010 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2017 | 4410 | 0.010 |
Why?
|
| Evidence-Based Medicine | 1 | 2016 | 3692 | 0.010 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2017 | 4652 | 0.010 |
Why?
|
| Sequence Analysis, DNA | 1 | 2014 | 4780 | 0.010 |
Why?
|
| Cell Line | 1 | 2016 | 15564 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2020 | 15912 | 0.010 |
Why?
|
| Incidence | 1 | 2019 | 21527 | 0.010 |
Why?
|
| Diagnosis, Differential | 1 | 2016 | 12985 | 0.010 |
Why?
|
| Mice, Transgenic | 1 | 2013 | 9546 | 0.010 |
Why?
|
| Stem Cells | 1 | 2013 | 3536 | 0.010 |
Why?
|
| Treatment Outcome | 2 | 2017 | 65286 | 0.010 |
Why?
|
| Prognosis | 1 | 2019 | 29959 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2017 | 22351 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2019 | 24299 | 0.010 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2013 | 4050 | 0.010 |
Why?
|
| Prevalence | 1 | 2014 | 15835 | 0.010 |
Why?
|
| Ovarian Neoplasms | 1 | 2013 | 4903 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2010 | 14653 | 0.010 |
Why?
|
| Skin Neoplasms | 1 | 2013 | 5860 | 0.010 |
Why?
|
| Inflammation | 1 | 2013 | 10863 | 0.010 |
Why?
|
| Risk Factors | 1 | 2019 | 74889 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2010 | 20146 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2013 | 23618 | 0.010 |
Why?
|
| Mice | 1 | 2013 | 81898 | 0.000 |
Why?
|
Concepts
(163)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(48)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_